Minot De Blois Advisors LLC Bristol Myers Squibb CO Transaction History
Minot De Blois Advisors LLC
- $109 Billion
- Q4 2024
A detailed history of Minot De Blois Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Minot De Blois Advisors LLC holds 298 shares of BMY stock, worth $16,220. This represents 0.02% of its overall portfolio holdings.
Number of Shares
298Holding current value
$16,220% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,745Shares Held
1.57BCall Options Held
27.9MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.3 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.64 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.23 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.18 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.28 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $116B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...